间甲苯甲酸酰肼 | 13050-47-0

• 物质功能分类: 化学试剂 - 有机试剂 - 芳烃
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 间甲苯甲酸酰肼
• 中文别名: 3-甲基苯甲酰肼；间苯甲酰肼；间甲苯甲酰肼
• 英文名称: 3-methylbenzoyl hydrazine
• 英文别名: 3-methylbenzohydrazide；3-methylbenzoic acid hydrazide
• CAS: 13050-47-0
• 化学式: C₈H₁₀N₂O
• mdl: MFCD00014760
• 分子量: 150.18
• InChiKey: XFNNAMBYJSQXKF-UHFFFAOYSA-N

物化性质

• 熔点：
  96 °C
• 稳定性/保质期：
  在常温常压下稳定，避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• 海关编码：
  2928000090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  请将物品存放在常温、密闭、避光、通风和干燥的地方。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
M-Toluic acid hydrazide
Product Name:
Synonyms: 3-Methylbenzohydrazide

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
M-Toluic acid hydrazide
Ingredient name:
CAS number: 13050-47-0

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H10N2O
Molecular weight: 150.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  间甲苯甲酸酰肼 在 吡啶 、 氢氧化钾 、 一水合肼 作用下， 生成 3-(3-methylphenyl)-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole-6-thione
  参考文献：
  名称：

  Mohan, Jag; Anjaneyulu, G. S. R.; Kiran, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1988, vol. 27, # 1-12, p. 128 - 131

  摘要：

  DOI：
• 作为产物：
  描述：

  3-甲基苯甲酸甲酯 在 一水合肼 作用下， 反应 10.0h， 生成 间甲苯甲酸酰肼
  参考文献：
  名称：

  三种新的芳酰hydr配体的氧化钒（V）配合物的合成，晶体结构和类胰岛素活性。

  摘要：

  通过C，H，N元素分析，单晶X射线衍射，UV / Vis和IR光谱设计，合成和表征了三种新型的氧化钒（V）配合物。配合物1：[VOL 1 X]（H 2 L 1  =（E）-N'-（2-羟基亚苄基）-3-甲基苯并肼，HX =乙基麦芽酚= 2-乙基-3-羟基-4-吡喃酮），配合物2 ： [VOL 2（CH 3 O）（CH 3 OH）]，（H 2 L 2  = C 16 H 16 N 2 O 4  =（E）-N'-（2-羟基苄叉）-3,5-二甲氧基苯甲酰肼，通道3OH ＝甲醇），络合物3：[VOL 3 X]（H 2 L 3  ＝（E）-N′-（3-乙氧基-2-羟基亚苄基）-3，5-二甲氧基苯并肼）。测试了三种复合物的胰岛素样活性。正常和链脲佐菌素（STZ）糖尿病小鼠均在胃内给药两周。发现以10.0和5.0mg V·kg -1的剂量的复合物可以显着降低STZ糖尿病小鼠的血糖水平，并且治疗的正常小鼠

  DOI：

  10.1016/j.jinorgbio.2019.03.020

文献信息

• Design and optimization of N-acylhydrazone pyrimidine derivatives as E. coli PDHc E1 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study
  作者：Haifeng He、Hongying Xia、Qin Xia、Yanliang Ren、Hongwu He

  DOI：10.1016/j.bmc.2017.08.038

  日期：2017.10

  binding site of Escherichia coli (E. coli) pyruvate dehydrogenase multienzyme complex E1 (PDHc E1), a series of novel ‘open-chain’ classes of ThDP analogs A, B, and C with N-acylhydrazone moieties was designed and synthesized to explore their activities against E. coli PHDc E1 in vitro and their inhibitory activity against microbial diseases were further evaluated in vivo. As a result, A1–23 exhibited moderate

  通过靶向硫胺二磷酸（THDP）结合位点的大肠杆菌（大肠杆菌）丙酮酸脱氢酶多酶复合物E1（PDHC E1），一系列的THDP小说“开链”类的类似物甲，乙，和Ç与ñ -设计并合成了酰基to部分，以探讨它们在体外对大肠杆菌PHDc E1的活性，并在体内进一步评价其对微生物疾病的抑制作用。结果，A1 – 23对大肠杆菌PDHc E1表现出了中度到强效的抑制活性（IC 50 = 0.15–23.55μM）。有效的抑制剂A13，A14，A15，C2具有很强的抑制活性，对大肠杆菌PDHc E1的IC 50值为0.60、0.15、0.39和0.34μM，并且在微生物和哺乳动物之间具有良好的酶选择性抑制作用。特别是，最有效的抑制剂A14可以控制99.37％的米地黄单胞菌（Xanthimonas oryzae pv）。Oryzae。此外，化合物A14在大肠杆菌中的结合特征对PDHc E1进行了研究，以通过分子
• The α-Effect in Hydrazinolysis of 4-Chloro-2-Nitrophenyl X-Substituted-Benzoates: Effect of Substituent X on Reaction Mechanism and the α-Effect
  作者：Min-Young Kim、Tae-Eun Kim、Jieun Lee、Ik-Hwan Um

  DOI：10.5012/bkcs.2014.35.8.2271

  日期：2014.8.20

  Second-order rate constants ($k_N$) have been measured spectrophotometrically for the reaction of 4-chloro-2-nitrophenyl X-substituted-benzoates (6a-6h) with a series of primary amines including hydrazine in 80 mol % $H_2O$/20 mol % DMSO at $25.0^\circ}C$. The Br$\o}$nsted-type plot for the reaction of 4-chloro-2-nitrophenyl benzoate (6d) is linear with $\beta}_nuc}$ = 0.74 when hydrazine is excluded from the correlation. Such a linear Br$\o}$nsted-type plot is typical for reactions reported previously to proceed through a stepwise mechanism in which expulsion of the leaving group occurs in the rate-determining step (RDS). The Hammett plots for the reactions of 6a-6h with hydrazine and glycylglycine are nonlinear. In contrast, the Yukawa-Tsuno plots exhibit excellent linear correlations with $\rho}_X$ = 1.29-1.45 and r = 0.53-0.56, indicating that the nonlinear Hammett plots are not due to a change in RDS but are caused by resonance stabilization of the substrates possessing an electron-donating group (EDG). Hydrazine is ca. 47-93 times more reactive than similarly basic glycylglycine toward 6a-6h (e.g., the $\alpha}$-effect). The $\alpha}$-effect increases as the substituent X in the benzoyl moiety becomes a stronger electron-withdrawing group (EWG), indicating that destabilization of the ground state (GS) of hydrazine through the repulsion between the nonbonding electron pairs on the two N atoms is not solely responsible for the substituent-dependent $\alpha}$-effect. Stabilization of transition state (TS) through five-membered cyclic TSs, which would increase the electrophilicity of the reaction center or the nucleofugality of the leaving group, contributes to the $\alpha}$-effect observed in this study.

  二次速率常数（$k_N$）已通过分光光度法测定，用于4-氯-2-硝基苯基X取代苯甲酸酯（6a-6h）与一系列伯胺（包括80摩尔% $H_2O$/20摩尔% DMSO中的25.0°C下的联氨）的反应。当联氨被排除在相关性之外时，4-氯-2-硝基苯基苯甲酸酯（6d）反应的Br$\o}$nsted型图是线性的，$\beta}_nuc}$ = 0.74。这种线性Br$\o}$nsted型图是典型的反应，先前报道这些反应通过逐步机制进行，其中离去基团的排出发生在速率决定步骤（RDS）中。6a-6h与联氨和甘氨酰甘氨酸反应的Hammett图是非线性的。相比之下，Yukawa-Tsuno图显示出极佳的线性相关性，$\rho}_X$ = 1.29-1.45，r = 0.53-0.56，表明非线性Hammett图并非由于RDS的变化，而是由于具有供电子基团（EDG）的底物的共振稳定化所导致。联氨对6a-6h的反应性大约是同样碱性的甘氨酰甘氨酸的47-93倍（例如，$\alpha}$效应）。随着苯甲酰基中取代基X成为更强的吸电子基团（EWG），$\alpha}$效应增加，表明通过两个N原子上的非键电子对之间的排斥来破坏联氨的基态（GS）并不是唯一导致取代基依赖的$\alpha}$效应的原因。通过五元环过渡态（TS）的稳定化，这将增加反应中心的亲电性或离去基团的离核性，有助于在本研究中观察到的$\alpha}$效应。
• Discovery of Functionally Selective 7,8,9,10-Tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-<i>a</i>]phthalazines as GABA_A Receptor Agonists at the α₃ Subunit
  作者：Michael G. N. Russell、Robert W. Carling、John R. Atack、Frances A. Bromidge、Susan M. Cook、Peter Hunt、Catherine Isted、Matt Lucas、Ruth M. McKernan、Andrew Mitchinson、Kevin W. Moore、Robert Narquizian、Alison J. Macaulay、David Thomas、Sally-Anne Thompson、Keith A. Wafford、José L. Castro

  DOI：10.1021/jm040883v

  日期：2005.3.1

  We have previously identified the 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazine (1) as a potent partial agonist for the alpha(3) receptor subtype with 5-fold selectivity in binding affinity over alpha(1). This paper describes a detailed investigation of the substituents on this core structure at both the 3- and 6-positions. Despite evaluating a wide range of groups, the maximum selectivity

  我们之前已经确定了7,8,9,10-四氢-7,10-乙醇-1,2,4-三唑并[3,4-a]酞嗪（1）是α（3）的有效部分激动剂。受体亚型，对α（1）的结合亲和力具有5倍的选择性。本文描述了在此核心结构的3位和6位上的取代基的详细研究。尽管评估了广泛的组，但相对于alpha（1）亚型，对alpha（3）亚型的亲和力可达到的最大选择性是12倍（对于57）。尽管大多数类似物在功效上均未显示选择性，但一些类似物确实在α（1）处表现出部分激动作用，而在α（3）处表现出拮抗作用（例如25和75）。但是，测试了两个类似物（93和96），它们都在6位上有三唑取代基，显示出对alpha（3）亚型的疗效明显高于alpha（1）亚型。这是该系列中可以在所需方向上实现选择性的第一个迹象。
• Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives
  作者：Khalid Mohammed Khan、Saira Qurban、Uzma Salar、Muhammad Taha、Shafqat Hussain、Shahnaz Perveen、Abdul Hameed、Nor Hadiani Ismail、Muhammad Riaz、Abdul Wadood

  DOI：10.1016/j.bioorg.2016.08.010

  日期：2016.10

  Current study based on the synthesis of new thiazole derivatives via "one pot" multicomponent reaction, evaluation of their in vitro α-glucosidase inhibitory activities, and in silico studies. All synthetic compounds were fully characterized by (1)H NMR, (13)C NMR and EIMS. CHN analysis was also performed. These newly synthesized compounds showed activities in the range of IC50=9.06±0.10-82.50±1.70μM

  当前的研究基于通过“一锅”多组分反应合成新的噻唑衍生物，评估其体外α-葡萄糖苷酶抑制活性以及计算机模拟研究。所有合成化合物均通过（1）H NMR，（13）C NMR和EIMS进行了全面表征。还进行了CHN分析。与标准阿卡波糖（IC50 = 38.25±0.12μM）相比，这些新合成的化合物显示的活性在IC50 = 9.06±0.10-82.50±1.70μM范围内。值得一提的是大多数化合物，例如1（IC50 = 23.60±0.39μM），2（IC50 = 22.70±0.60μM），3（IC50 = 22.40±0.32μM），4（IC50 = 26.5±0.40μM） ，6（IC50 = 34.60±0.60μM），7（IC50 = 26.20±0.43μM），8（IC50 = 14.06±0.18μM），9（IC50 = 17.60±0.28μM），10（IC50 = 27.16±0
• Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors
  作者：Mehr-un Nisa、Munawar A. Munawar、Amber Iqbal、Asrar Ahmed、Muhammad Ashraf、Qurra-tul-Ann A. Gardener、Misbahul A. Khan

  DOI：10.1016/j.ejmech.2017.06.036

  日期：2017.9

  A novel series of 5-(aroylhydrazinocarbonyl)escitalopram (58–84) have been designed, synthesized and tested for their inhibitory potential against cholinesterases. 3-Chlorobenzoyl- (71) was found to be the most potent compound of this series having IC50 1.80 ± 0.11 μM for acetylcholinesterase (AChE) inhibition. For the butyrylcholinesterase (BChE) inhibition, 2-bromobenzoyl- (76) was the most active

  已经设计，合成和测试了一系列新型的5-（芳酰基肼基羰基）依他普仑（58-84）对胆碱酯酶的抑制潜力。发现3-氯苯甲酰基- （71）是该系列中最有效的化合物，对乙酰胆碱酯酶（AChE）的抑制作用的IC 50为1.80±0.11μM。对于丁酰胆碱酯酶（BChE）抑制，2-溴苯甲酰基-（76）是该系列中活性最高的化合物，IC 50为2.11±0.31μM。构效关系说明温和的给电子基团增强了酶的抑制作用，而吸电子基团降低了除o -NO 2以外的抑制。然而，取代基的大小和位置影响酶抑制。。在AChE的对接研究中，配体71、72和76分别显示5874、5756和5666以及ACE的得分分别为-64.92，-203.25和-140.29 kcal / mol。在BChE的情况下，配体71、76和81分别显示出ACE值为-170.91，-256.84和-235.97 kcal / mol的高分6016、6150和5994。

表征谱图